2020, Number 6
<< Back Next >>
Rev Méd Electrón 2020; 42 (6)
Depression in seriously-ill elder people with community-acquired pneumonia
Martínez CT, García ÁPJ
Language: Spanish
References: 20
Page:
PDF size: 117.23 Kb.
ABSTRACT
Introduction:
those countries with a high level of population ageing show important associations to different diseases, for example, community acquired pneumonia and depression in elder people.
Objectives:
to establish the relationship of depression with mortality and to evaluate the effect of antidepressants in patients with community-acquired pneumonia admitted in the Intensive Care Unit of the Central Military Hospital “Dr. Carlos J. Finlay”.
Materials and methods:
a prospective, longitudinal, analytic study was carried out with all patients with community-acquired pneumonia, admitted in the Intensive Care Unit of the Central Military Hospital “Dr. Carlos J. Finlay” in the period from January 2018 until April 2019, who fulfilled the inclusion criteria. The universe were 160 patients.
Results:
there were 55 patients with depression symptoms before the admission. 78 % of the deceased showed depression at the admittance. The medium age of the non-depressed ones was 74 years; the highest age of the depressed ones was 80.80 years. 93 living patients did not present depression signs, and 43 presented them and died with a great statistical significance p: 0.000 RR: 6.8. A remarked relation was observed between mortality and not receiving treatment for depression (37) p 0,000.
Conclusions:
pneumonia and depression are diseases having a tight relationship. This association yields a high mortality, and the impact of the anti-depression treatment on the patient’s evolution is defining in the intensive care settings.
REFERENCES
Society of General Internal Medicine. Abstracts from the 2017 Society of General Internal Medicine Annual Meeting.J Gen Intern Med. 2017 ; 32(Suppl 2): 83-808. Citado en PubMed; PMID: 28397154.
Infomed. Neumonología. Historia de la Neumonía[Internet]. La Habana: Infomed;2013 [citado 01/09/2017]. Disponible en: Disponible en: https://articulos.sld.cu/neumologia/2013/03/01/historia-de-la-neumonia/
Lara Aguayo P, Rojas Amezcua M, De-la-Fuente Martos C, et al. Neumonía adquirida en a comunidad. En: Fotoletra SA, Tratado de Medicina Intensiva. España: Elsevier; 2017. p. 659.
Lara Aguayo P, Rojas Amezcua M, De-la-Fuente Martos C, et al. Neumonía adquirida en a comunidad. En: Fotoletra SA, Tratado de Medicina Intensiva. España: Elsevier ; 2017. p. 659.
Infomed. Anuario estadístico de la Salud. 2016[Internet]. La Habana: Ministerio de Salud Pública; 2017[citado 01/09/2017]. Disponible en: Disponible en: http://www.sld.cu/noticia/2017/04/13/publicado-el-anuario-estadistico-de-salud-2016
Ping-Hsun W, Ming-Yen L, Teng-Hui H, et al. Depression amongst patients commencing maintenance dialysis is associated with increased risk of death and severe infections: A nationwide cohort study.PLoS One. 2019; 14(6): e0218335.Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218335
Ford B, Yolken R, Dickerson F, et al. Reduced Immunity to Measles in Adults with Major Depressive Disorder.Psychol Med. 2019 ; 49(2): 243-49. Citado en PubMed; PMID: 29552990.
Raison C. Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology,Genetics, Bioregional Differences and Female Preponderance. Neuropsychopharmacology. 2017 ; 42(1): 5-27. Citado en PubMed; PMID: 27629366
Gong W, Zhu S, Chen C, et al. The Anti-depression Effect of Angelicae Sinensis Radix Is Related to the Pharmacological Activity of Modulating the Hematological Anomalies.Front Pharmacol. 2019 ;10 :192. Citado en PubMed; PMID: 30894817.
Quintana Rodriguez I, Velazco Fajardo Y. Reacciones adversas de los antidepresivos: consideraciones actuales. Rev Méd Electrón [Internet]. 2018 [citado 13/08/2019];40(2).Disponible en: Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/1964/3781
Celis Sierra M. El último metaanálisis sobre antidepresivos:Nada nuevo bajo el sol. Rev Clínica Contemporánea[Internet]. 2018[citado 13/08/2019]; 9, (7):1-5.Disponible en: Disponible en: https://www.revistaclinicacontemporanea.org/art/cc2018a7
Ventorp F, Gustafsson A, Träskman-Bendz L, et al. Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters. PLoS One . 2015; 10(10). Citado en PubMed; PMID: 26451727.
Sun Y, Narayan V, Wittenberg G. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders.BMC Pharmacol Toxicol. 2016; 17(1): 47. Citado en PubMed; PMID: 27765060.
ACNP. 56th Annual Meeting: Poster Session III, December 6, 2017. Neuropsychopharmacology [Internet]. 2017 [citado 13/08/2019]; 42(Suppl 1): S476-S652. Disponible en: Disponible en: https://www.nature.com/articles/npp2017266
Francis BA, Beaumont J, Maas MB, et al. Depressive symptom prevalence after intracerebral hemorrhage: a multi-center study. J Patient Rep Outcomes. 2018;2(1):55. doi:10.1186/s41687-018-0083-0
16 DeWaters AL, Chansard M, Anzueto A, Pugh MJ, Mortensen EM. The Association Between Major Depressive Disorder and Outcomes in Older Veterans Hospitalized With Pneumonia. Am J Med Sci. 2018;355(1):21-26. doi:10.1016/j.amjms.2017.08.015
Demircan F, Gözel N, Kılınç F, Ulu R, Atmaca M. The Impact of Red Blood Cell Distribution Width and Neutrophil/Lymphocyte Ratio on the Diagnosis of Major Depressive Disorder. Neurol Ther. 2016;5(1):27-33. doi:10.1007/s40120-015-0039-8
Ford B, Yolken R, Dickerson F, et al. Reduced Immunity to Measles in Adults with Major Depressive Disorder.Psychol Med. 2019 ; 49(2): 243-249. doi:10.1017/S0033291718000661
Raison C, Miller A. Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology,Genetics, Bioregional Differences and Female Preponderance. Neuropsychopharmacology . 2017 ; 42(1): 5-27. doi:10.1038/npp.2016.194
Iyer A, Bhatt S, Garner J, et al. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 ; 13(2): 197-203. doi:10.1513/AnnalsATS.201507-439OC.